Update: Lawsuit for Investors in shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) announced by Shareholders Foundation
SAN DIEGO, CA / ACCESSWIRE / January 7, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR).
Investors, who purchased shares of Esperion Therapeutics, Inc. (ESPR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On May 2, 2018, Esperion Therapeutics, Inc announced results from its second pivotal Phase 3 study for its cholesterol-lowering medication. Esperion Therapeutics, Inc reported that while the trial met the primary endpoint of safety and tolerability and the key efficacy endpoint, there were 13 deaths in the treatment group compared to only two in the control group.
On May 7, 2018, a lawsuit was filed against Esperion Therapeutics, Inc. over alleged securities laws violations. More specifically, the plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that Esperion's cholesterol-lowering medication, bempedoic acid, entailed serious undisclosed safety risks, including death, and that as a result of the foregoing, Esperion's public statements were materially false and misleading at all relevant times.
On October 22, 2018, an amended complaint was filed.
Those who purchased Esperion Therapeutics, Inc. (ESPR) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced case, investigation, and/or settlement is not filed/initiated/reached and/or is not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
SOURCE: Shareholders Foundation, Inc.
